Latest Insider Transactions at Harvard Bioscience Inc (HBIO)
This section provides a real-time view of insider transactions for Harvard Bioscience Inc (HBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HARVARD BIOSCIENCE INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HARVARD BIOSCIENCE INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Michael A. Rossi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,737
+10.01%
|
-
|
|
Jan 01
2022
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+1.85%
|
-
|
|
Jan 01
2022
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+1.24%
|
-
|
|
Jan 01
2022
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,424
-2.34%
|
$331,968
$7.05 P/Share
|
|
Jan 01
2022
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+1.34%
|
-
|
|
Jan 01
2022
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,489
+1.51%
|
-
|
|
Dec 29
2021
|
Michael A. Rossi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,926
-1.51%
|
$48,482
$7.27 P/Share
|
|
Dec 29
2021
|
James W Green Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,970
-1.28%
|
$370,790
$7.27 P/Share
|
|
Dec 29
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,159
-1.92%
|
$43,113
$7.27 P/Share
|
|
Dec 28
2021
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+0.7%
|
-
|
|
Dec 28
2021
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+1.05%
|
-
|
|
Dec 28
2021
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+0.76%
|
-
|
|
Dec 28
2021
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,401
+0.48%
|
-
|
|
Nov 12
2021
|
James W Green Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
13,777
-0.66%
|
-
|
|
Nov 01
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,539
-0.94%
|
$10,773
$7.37 P/Share
|
|
Aug 23
2021
|
James W Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
48,175
-2.25%
|
$385,400
$8.02 P/Share
|
|
Jul 18
2021
|
Michael A. Rossi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,966
-2.93%
|
$48,762
$7.57 P/Share
|
|
Jul 08
2021
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
200,575
-4.38%
|
$1,604,600
$8.03 P/Share
|
|
Jun 11
2021
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,373
-2.03%
|
$338,611
$7.64 P/Share
|
|
Jun 11
2021
|
James W Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,070
+4.37%
|
-
|
|
Jun 11
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,480
-3.82%
|
$45,360
$7.64 P/Share
|
|
Jun 11
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,378
+9.77%
|
-
|
|
Jun 11
2021
|
Michael A. Rossi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,172
-2.53%
|
$43,204
$7.64 P/Share
|
|
Jun 11
2021
|
Michael A. Rossi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,546
+8.11%
|
-
|
|
May 25
2021
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,400
+9.95%
|
-
|
|
May 25
2021
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,400
+6.8%
|
-
|
|
May 25
2021
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,400
+4.78%
|
-
|
|
May 25
2021
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,400
+7.34%
|
-
|
|
May 21
2021
|
James W Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,312
-1.06%
|
$170,184
$7.14 P/Share
|
|
May 21
2021
|
James W Green Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,312
+1.04%
|
$48,624
$2.63 P/Share
|
|
May 20
2021
|
James W Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,876
-0.65%
|
$104,132
$7.03 P/Share
|
|
May 20
2021
|
James W Green Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,876
+0.64%
|
$29,752
$2.63 P/Share
|
|
May 19
2021
|
James W Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
39,188
-1.69%
|
$274,316
$7.17 P/Share
|
|
May 19
2021
|
James W Green Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,188
+1.66%
|
$78,376
$2.63 P/Share
|
|
May 18
2021
|
James W Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
39,188
-1.69%
|
$274,316
$7.41 P/Share
|
|
May 18
2021
|
James W Green Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,188
+1.66%
|
$78,376
$2.63 P/Share
|
|
Mar 23
2021
|
John F Kennedy Director |
SELL
Bona fide gift
|
Direct |
6,895
-2.09%
|
-
|
|
Mar 17
2021
|
John F Kennedy Director |
SELL
Bona fide gift
|
Direct |
12,500
-1.84%
|
-
|
|
Mar 12
2021
|
James W Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,000
-1.51%
|
$175,000
$5.98 P/Share
|
|
Mar 01
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,258
+19.34%
|
-
|
|
Mar 01
2021
|
Michael A. Rossi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,338
+15.68%
|
-
|
|
Mar 01
2021
|
James W Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
381,372
+7.92%
|
-
|
|
Jan 04
2021
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+7.2%
|
-
|
|
Jan 04
2021
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,300
+12.33%
|
-
|
|
Jan 04
2021
|
John F Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,200
+3.71%
|
-
|
|
Jan 04
2021
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,300
+8.38%
|
-
|
|
Jan 04
2021
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,300
+7.25%
|
-
|
|
Jan 04
2021
|
Susan M. Steele Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+17.94%
|
-
|
|
Jan 01
2021
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30,478
-1.55%
|
$121,912
$4.29 P/Share
|
|
Dec 31
2020
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,231
-1.32%
|
$104,924
$4.29 P/Share
|